EP3626253 - STABLE FORMULATIONS OF LINACLOTIDE [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 20.01.2023 Database last updated on 02.09.2024 | |
Former | The patent has been granted Status updated on 11.02.2022 | ||
Former | Grant of patent is intended Status updated on 28.06.2021 | ||
Former | Request for examination was made Status updated on 05.02.2021 | ||
Former | The application has been published Status updated on 21.02.2020 | Most recent event Tooltip | 31.05.2024 | Lapse of the patent in a contracting state New state(s): MK | published on 03.07.2024 [2024/27] | Applicant(s) | For all designated states Ironwood Pharmaceuticals, Inc. 301 Binney Street Cambridge, MA 02142 / US | For all designated states Allergan Pharmaceuticals International Limited Clonshaugh Business & Technology Park Dublin 17, D17 E400 / IE | [2022/13] |
Former [2020/13] | For all designated states Ironwood Pharmaceuticals, Inc. 301 Binney Street Cambridge, MA 02142 / US | ||
For all designated states Forest Laboratories Holdings Limited Victoria Place, 5th Floor 31 Victoria Street Hamilton / BM | Inventor(s) | 01 /
MO, Yun 260 Middle Neck Road, Apt. 3L Great Neck, NY 11021 / US | 02 /
FRETZEN, Angelika 7 Avon Street Somerville, MA Massachusetts 02143 / US | 03 /
CALI, Brian 100 Hillside Avenue Arlington, MA Massachusetts 02476 / US | 04 /
DEDHIYA, Mahendra 1 Lea Court Pomona, NY New York 10970 / US | [2020/13] | Representative(s) | Drywood, Rosalind Aerona, et al Mathys & Squire The Shard 32 London Bridge Street London SE1 9SG / GB | [2022/11] |
Former [2020/13] | Drywood, Rosalind Aerona, et al Mathys & Squire LLP The Shard 32 London Bridge Street London SE1 9SG / GB | Application number, filing date | 19191344.1 | 11.08.2011 | [2020/13] | Priority number, date | US201037280410P | 11.08.2010 Original published format: US 37280410 P | [2020/13] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | EP3626253 | Date: | 25.03.2020 | Language: | EN | [2020/13] | Type: | A3 Search report | No.: | EP3626253 | Date: | 29.07.2020 | Language: | EN | [2020/31] | Type: | B1 Patent specification | No.: | EP3626253 | Date: | 16.03.2022 | Language: | EN | [2022/11] | Type: | B8 Corrected title page of specification | No.: | EP3626253 | Date: | 20.04.2022 | [2022/16] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 30.06.2020 | Classification | IPC: | A61K38/10, A61K9/20, A61K47/18, A61P1/00 | [2020/13] | CPC: |
A61K38/12 (EP,US);
A61K38/10 (EP,US);
A61K47/18 (US);
A61K9/1611 (EP,US);
A61K9/1641 (EP,US);
A61K9/1676 (EP,US);
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2021/10] |
Former [2020/13] | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR | Extension states | BA | 12.08.2019 | ME | 12.08.2019 | Title | German: | STABILE LINACLOTIDFORMULIERUNGEN | [2020/13] | English: | STABLE FORMULATIONS OF LINACLOTIDE | [2020/13] | French: | FORMULATIONS STABLES DE LINACLOTIDE | [2020/13] | Examination procedure | 29.01.2021 | Amendment by applicant (claims and/or description) | 29.01.2021 | Examination requested [2021/10] | 29.01.2021 | Date on which the examining division has become responsible | 29.06.2021 | Communication of intention to grant the patent | 01.12.2021 | Despatch of communication that the application is deemed to be withdrawn, reason: fee for grant / fee for printing not paid in time | 01.02.2022 | Fee for grant paid | 01.02.2022 | Fee for publishing/printing paid | 01.02.2022 | Receipt of the translation of the claim(s) | Parent application(s) Tooltip | EP11745896.8 / EP2603232 | Opposition(s) | 19.12.2022 | No opposition filed within time limit [2023/08] | Request for further processing for: | The application is deemed to be withdrawn due to failure to fulfill actions required for granting the patent | 01.02.2022 | Request for further processing filed | 01.02.2022 | Full payment received (date of receipt of payment) Request granted | 10.02.2022 | Decision despatched | Fees paid | Renewal fee | 12.08.2019 | Renewal fee patent year 03 | 12.08.2019 | Renewal fee patent year 04 | 12.08.2019 | Renewal fee patent year 05 | 12.08.2019 | Renewal fee patent year 06 | 12.08.2019 | Renewal fee patent year 07 | 12.08.2019 | Renewal fee patent year 08 | 12.08.2019 | Renewal fee patent year 09 | 13.08.2020 | Renewal fee patent year 10 | 13.08.2021 | Renewal fee patent year 11 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | HU | 11.08.2011 | AL | 16.03.2022 | AT | 16.03.2022 | CY | 16.03.2022 | CZ | 16.03.2022 | DK | 16.03.2022 | EE | 16.03.2022 | FI | 16.03.2022 | HR | 16.03.2022 | LT | 16.03.2022 | LV | 16.03.2022 | MC | 16.03.2022 | MK | 16.03.2022 | NL | 16.03.2022 | PL | 16.03.2022 | RO | 16.03.2022 | RS | 16.03.2022 | SE | 16.03.2022 | SI | 16.03.2022 | SK | 16.03.2022 | SM | 16.03.2022 | BG | 16.06.2022 | NO | 16.06.2022 | GR | 17.06.2022 | IS | 16.07.2022 | PT | 18.07.2022 | IE | 11.08.2022 | LU | 11.08.2022 | BE | 31.08.2022 | CH | 31.08.2022 | LI | 31.08.2022 | [2024/27] |
Former [2024/21] | HU | 11.08.2011 | |
AL | 16.03.2022 | ||
AT | 16.03.2022 | ||
CY | 16.03.2022 | ||
CZ | 16.03.2022 | ||
DK | 16.03.2022 | ||
EE | 16.03.2022 | ||
FI | 16.03.2022 | ||
HR | 16.03.2022 | ||
LT | 16.03.2022 | ||
LV | 16.03.2022 | ||
MC | 16.03.2022 | ||
NL | 16.03.2022 | ||
PL | 16.03.2022 | ||
RO | 16.03.2022 | ||
RS | 16.03.2022 | ||
SE | 16.03.2022 | ||
SI | 16.03.2022 | ||
SK | 16.03.2022 | ||
SM | 16.03.2022 | ||
BG | 16.06.2022 | ||
NO | 16.06.2022 | ||
GR | 17.06.2022 | ||
IS | 16.07.2022 | ||
PT | 18.07.2022 | ||
IE | 11.08.2022 | ||
LU | 11.08.2022 | ||
BE | 31.08.2022 | ||
CH | 31.08.2022 | ||
LI | 31.08.2022 | ||
Former [2024/18] | HU | 11.08.2011 | |
AL | 16.03.2022 | ||
AT | 16.03.2022 | ||
CZ | 16.03.2022 | ||
DK | 16.03.2022 | ||
EE | 16.03.2022 | ||
FI | 16.03.2022 | ||
HR | 16.03.2022 | ||
LT | 16.03.2022 | ||
LV | 16.03.2022 | ||
MC | 16.03.2022 | ||
NL | 16.03.2022 | ||
PL | 16.03.2022 | ||
RO | 16.03.2022 | ||
RS | 16.03.2022 | ||
SE | 16.03.2022 | ||
SI | 16.03.2022 | ||
SK | 16.03.2022 | ||
SM | 16.03.2022 | ||
BG | 16.06.2022 | ||
NO | 16.06.2022 | ||
GR | 17.06.2022 | ||
IS | 16.07.2022 | ||
PT | 18.07.2022 | ||
IE | 11.08.2022 | ||
LU | 11.08.2022 | ||
BE | 31.08.2022 | ||
CH | 31.08.2022 | ||
LI | 31.08.2022 | ||
Former [2023/42] | AL | 16.03.2022 | |
AT | 16.03.2022 | ||
CZ | 16.03.2022 | ||
DK | 16.03.2022 | ||
EE | 16.03.2022 | ||
FI | 16.03.2022 | ||
HR | 16.03.2022 | ||
LT | 16.03.2022 | ||
LV | 16.03.2022 | ||
MC | 16.03.2022 | ||
NL | 16.03.2022 | ||
PL | 16.03.2022 | ||
RO | 16.03.2022 | ||
RS | 16.03.2022 | ||
SE | 16.03.2022 | ||
SI | 16.03.2022 | ||
SK | 16.03.2022 | ||
SM | 16.03.2022 | ||
BG | 16.06.2022 | ||
NO | 16.06.2022 | ||
GR | 17.06.2022 | ||
IS | 16.07.2022 | ||
PT | 18.07.2022 | ||
IE | 11.08.2022 | ||
LU | 11.08.2022 | ||
BE | 31.08.2022 | ||
CH | 31.08.2022 | ||
LI | 31.08.2022 | ||
Former [2023/33] | AL | 16.03.2022 | |
AT | 16.03.2022 | ||
CZ | 16.03.2022 | ||
DK | 16.03.2022 | ||
EE | 16.03.2022 | ||
FI | 16.03.2022 | ||
HR | 16.03.2022 | ||
LT | 16.03.2022 | ||
LV | 16.03.2022 | ||
MC | 16.03.2022 | ||
NL | 16.03.2022 | ||
PL | 16.03.2022 | ||
RO | 16.03.2022 | ||
RS | 16.03.2022 | ||
SE | 16.03.2022 | ||
SI | 16.03.2022 | ||
SK | 16.03.2022 | ||
SM | 16.03.2022 | ||
BG | 16.06.2022 | ||
NO | 16.06.2022 | ||
GR | 17.06.2022 | ||
IS | 16.07.2022 | ||
PT | 18.07.2022 | ||
IE | 11.08.2022 | ||
LU | 11.08.2022 | ||
CH | 31.08.2022 | ||
LI | 31.08.2022 | ||
Former [2023/21] | AL | 16.03.2022 | |
AT | 16.03.2022 | ||
CZ | 16.03.2022 | ||
DK | 16.03.2022 | ||
EE | 16.03.2022 | ||
FI | 16.03.2022 | ||
HR | 16.03.2022 | ||
LT | 16.03.2022 | ||
LV | 16.03.2022 | ||
MC | 16.03.2022 | ||
NL | 16.03.2022 | ||
PL | 16.03.2022 | ||
RO | 16.03.2022 | ||
RS | 16.03.2022 | ||
SE | 16.03.2022 | ||
SI | 16.03.2022 | ||
SK | 16.03.2022 | ||
SM | 16.03.2022 | ||
BG | 16.06.2022 | ||
NO | 16.06.2022 | ||
GR | 17.06.2022 | ||
IS | 16.07.2022 | ||
PT | 18.07.2022 | ||
LU | 11.08.2022 | ||
CH | 31.08.2022 | ||
LI | 31.08.2022 | ||
Former [2023/16] | AL | 16.03.2022 | |
AT | 16.03.2022 | ||
CZ | 16.03.2022 | ||
DK | 16.03.2022 | ||
EE | 16.03.2022 | ||
FI | 16.03.2022 | ||
HR | 16.03.2022 | ||
LT | 16.03.2022 | ||
LV | 16.03.2022 | ||
MC | 16.03.2022 | ||
NL | 16.03.2022 | ||
PL | 16.03.2022 | ||
RO | 16.03.2022 | ||
RS | 16.03.2022 | ||
SE | 16.03.2022 | ||
SI | 16.03.2022 | ||
SK | 16.03.2022 | ||
SM | 16.03.2022 | ||
BG | 16.06.2022 | ||
NO | 16.06.2022 | ||
GR | 17.06.2022 | ||
IS | 16.07.2022 | ||
PT | 18.07.2022 | ||
Former [2023/10] | AL | 16.03.2022 | |
AT | 16.03.2022 | ||
CZ | 16.03.2022 | ||
DK | 16.03.2022 | ||
EE | 16.03.2022 | ||
FI | 16.03.2022 | ||
HR | 16.03.2022 | ||
LT | 16.03.2022 | ||
LV | 16.03.2022 | ||
NL | 16.03.2022 | ||
PL | 16.03.2022 | ||
RO | 16.03.2022 | ||
RS | 16.03.2022 | ||
SE | 16.03.2022 | ||
SI | 16.03.2022 | ||
SK | 16.03.2022 | ||
SM | 16.03.2022 | ||
BG | 16.06.2022 | ||
NO | 16.06.2022 | ||
GR | 17.06.2022 | ||
IS | 16.07.2022 | ||
PT | 18.07.2022 | ||
Former [2023/07] | AL | 16.03.2022 | |
AT | 16.03.2022 | ||
CZ | 16.03.2022 | ||
DK | 16.03.2022 | ||
EE | 16.03.2022 | ||
FI | 16.03.2022 | ||
HR | 16.03.2022 | ||
LT | 16.03.2022 | ||
LV | 16.03.2022 | ||
NL | 16.03.2022 | ||
PL | 16.03.2022 | ||
RO | 16.03.2022 | ||
RS | 16.03.2022 | ||
SE | 16.03.2022 | ||
SK | 16.03.2022 | ||
SM | 16.03.2022 | ||
BG | 16.06.2022 | ||
NO | 16.06.2022 | ||
GR | 17.06.2022 | ||
IS | 16.07.2022 | ||
PT | 18.07.2022 | ||
Former [2023/01] | AL | 16.03.2022 | |
AT | 16.03.2022 | ||
CZ | 16.03.2022 | ||
EE | 16.03.2022 | ||
FI | 16.03.2022 | ||
HR | 16.03.2022 | ||
LT | 16.03.2022 | ||
LV | 16.03.2022 | ||
NL | 16.03.2022 | ||
PL | 16.03.2022 | ||
RO | 16.03.2022 | ||
RS | 16.03.2022 | ||
SE | 16.03.2022 | ||
SK | 16.03.2022 | ||
SM | 16.03.2022 | ||
BG | 16.06.2022 | ||
NO | 16.06.2022 | ||
GR | 17.06.2022 | ||
IS | 16.07.2022 | ||
PT | 18.07.2022 | ||
Former [2022/51] | AT | 16.03.2022 | |
CZ | 16.03.2022 | ||
EE | 16.03.2022 | ||
FI | 16.03.2022 | ||
HR | 16.03.2022 | ||
LT | 16.03.2022 | ||
LV | 16.03.2022 | ||
NL | 16.03.2022 | ||
PL | 16.03.2022 | ||
RO | 16.03.2022 | ||
RS | 16.03.2022 | ||
SE | 16.03.2022 | ||
SK | 16.03.2022 | ||
SM | 16.03.2022 | ||
BG | 16.06.2022 | ||
NO | 16.06.2022 | ||
GR | 17.06.2022 | ||
IS | 16.07.2022 | ||
PT | 18.07.2022 | ||
Former [2022/50] | AT | 16.03.2022 | |
CZ | 16.03.2022 | ||
EE | 16.03.2022 | ||
FI | 16.03.2022 | ||
HR | 16.03.2022 | ||
LT | 16.03.2022 | ||
LV | 16.03.2022 | ||
NL | 16.03.2022 | ||
PL | 16.03.2022 | ||
RO | 16.03.2022 | ||
RS | 16.03.2022 | ||
SE | 16.03.2022 | ||
SK | 16.03.2022 | ||
SM | 16.03.2022 | ||
BG | 16.06.2022 | ||
NO | 16.06.2022 | ||
GR | 17.06.2022 | ||
PT | 18.07.2022 | ||
Former [2022/49] | AT | 16.03.2022 | |
CZ | 16.03.2022 | ||
EE | 16.03.2022 | ||
FI | 16.03.2022 | ||
HR | 16.03.2022 | ||
LT | 16.03.2022 | ||
LV | 16.03.2022 | ||
NL | 16.03.2022 | ||
RO | 16.03.2022 | ||
RS | 16.03.2022 | ||
SE | 16.03.2022 | ||
SK | 16.03.2022 | ||
SM | 16.03.2022 | ||
BG | 16.06.2022 | ||
NO | 16.06.2022 | ||
GR | 17.06.2022 | ||
PT | 18.07.2022 | ||
Former [2022/48] | AT | 16.03.2022 | |
CZ | 16.03.2022 | ||
EE | 16.03.2022 | ||
FI | 16.03.2022 | ||
HR | 16.03.2022 | ||
LT | 16.03.2022 | ||
LV | 16.03.2022 | ||
NL | 16.03.2022 | ||
RO | 16.03.2022 | ||
RS | 16.03.2022 | ||
SE | 16.03.2022 | ||
SM | 16.03.2022 | ||
BG | 16.06.2022 | ||
NO | 16.06.2022 | ||
GR | 17.06.2022 | ||
PT | 18.07.2022 | ||
Former [2022/47] | AT | 16.03.2022 | |
FI | 16.03.2022 | ||
HR | 16.03.2022 | ||
LT | 16.03.2022 | ||
LV | 16.03.2022 | ||
NL | 16.03.2022 | ||
RO | 16.03.2022 | ||
RS | 16.03.2022 | ||
SE | 16.03.2022 | ||
SM | 16.03.2022 | ||
BG | 16.06.2022 | ||
NO | 16.06.2022 | ||
GR | 17.06.2022 | ||
PT | 18.07.2022 | ||
Former [2022/44] | FI | 16.03.2022 | |
HR | 16.03.2022 | ||
LT | 16.03.2022 | ||
LV | 16.03.2022 | ||
NL | 16.03.2022 | ||
RS | 16.03.2022 | ||
SE | 16.03.2022 | ||
BG | 16.06.2022 | ||
NO | 16.06.2022 | ||
GR | 17.06.2022 | ||
Former [2022/39] | FI | 16.03.2022 | |
HR | 16.03.2022 | ||
LT | 16.03.2022 | ||
LV | 16.03.2022 | ||
RS | 16.03.2022 | ||
SE | 16.03.2022 | ||
BG | 16.06.2022 | ||
NO | 16.06.2022 | ||
GR | 17.06.2022 | ||
Former [2022/36] | HR | 16.03.2022 | |
LT | 16.03.2022 | ||
LV | 16.03.2022 | ||
RS | 16.03.2022 | ||
SE | 16.03.2022 | ||
BG | 16.06.2022 | ||
NO | 16.06.2022 | ||
GR | 17.06.2022 | ||
Former [2022/35] | HR | 16.03.2022 | |
LT | 16.03.2022 | ||
RS | 16.03.2022 | ||
SE | 16.03.2022 | ||
BG | 16.06.2022 | ||
NO | 16.06.2022 | ||
Former [2022/33] | LT | 16.03.2022 | |
NO | 16.06.2022 | Documents cited: | Search | [A]EP1908482 (CHUGAI PHARMACEUTICAL CO LTD [JP]) [A] 1-4,6-12,14 * abstract *; | [A]WO2010019266 (IRONWOOD PHARMACEUTICALS INC [US], et al) [A] 1-4,6-12,14 * abstract *; | [A] - FUJITA MEGUMI ET AL, "Stabilization by meglumine of an amine compound degraded by formaldehyde in tablets.", INTERNATIONAL JOURNAL OF PHARMACEUTICS 15 FEB 2010 LNKD- PUBMED:19931605, (20100215), vol. 386, no. 1-2, ISSN 1873-3476, pages 195 - 200, XP002662715 [A] 1-4,6-12,14 * abstract * DOI: http://dx.doi.org/10.1016/j.ijpharm.2009.11.017 | by applicant | US7304036 | US7371727 | US20100372804 |